Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130


MicroRNA-194 inhibits the epithelial-mesenchymal transition in gastric cancer cells by targeting FoxM1.

Li Z, Ying X, Chen H, Ye P, Shen Y, Pan W, Zhang L.

Dig Dis Sci. 2014 Sep;59(9):2145-52. doi: 10.1007/s10620-014-3159-6. Epub 2014 Apr 19.


miR-204 inhibits invasion and epithelial-mesenchymal transition by targeting FOXM1 in esophageal cancer.

Sun Y, Yu X, Bai Q.

Int J Clin Exp Pathol. 2015 Oct 1;8(10):12775-83. eCollection 2015.


miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.

Tan X, Fu Y, Chen L, Lee W, Lai Y, Rezaei K, Tabbara S, Latham P, Teal CB, Man YG, Siegel RS, Brem RF, Fu SW.

Oncotarget. 2016 Jan 5;7(1):293-307. doi: 10.18632/oncotarget.6344.


Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells.

Bao B, Wang Z, Ali S, Kong D, Banerjee S, Ahmad A, Li Y, Azmi AS, Miele L, Sarkar FH.

J Cell Biochem. 2011 Sep;112(9):2296-306. doi: 10.1002/jcb.23150. Erratum in: J Cell Biochem. 2016 Aug;117(8):1963.


MicroRNA-630 Suppresses Epithelial-to-Mesenchymal Transition by Regulating FoxM1 in Gastric Cancer Cells.

Feng J, Wang X, Zhu W, Chen S, Feng C.

Biochemistry (Mosc). 2017 Jun;82(6):707-714. doi: 10.1134/S0006297917060074.


miR-134 inhibits epithelial to mesenchymal transition by targeting FOXM1 in non-small cell lung cancer cells.

Li J, Wang Y, Luo J, Fu Z, Ying J, Yu Y, Yu W.

FEBS Lett. 2012 Oct 19;586(20):3761-5. doi: 10.1016/j.febslet.2012.09.016. Epub 2012 Sep 23.


Down-regulation of FoxM1 leads to the inhibition of the epithelial-mesenchymal transition in gastric cancer cells.

Miao L, Xiong X, Lin Y, Cheng Y, Lu J, Zhang J, Cheng N.

Cancer Genet. 2014 Mar;207(3):75-82. doi: 10.1016/j.cancergen.2014.02.008. Epub 2014 Feb 27.


FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.

Meng FD, Wei JC, Qu K, Wang ZX, Wu QF, Tai MH, Liu HC, Zhang RY, Liu C.

World J Gastroenterol. 2015 Jan 7;21(1):196-213. doi: 10.3748/wjg.v21.i1.196.


FoxM1 is overexpressed in Helicobacter pylori-induced gastric carcinogenesis and is negatively regulated by miR-370.

Feng Y, Wang L, Zeng J, Shen L, Liang X, Yu H, Liu S, Liu Z, Sun Y, Li W, Chen C, Jia J.

Mol Cancer Res. 2013 Aug;11(8):834-44. doi: 10.1158/1541-7786.MCR-13-0007. Epub 2013 Apr 10.


MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma.

Kurashige J, Kamohara H, Watanabe M, Hiyoshi Y, Iwatsuki M, Tanaka Y, Kinoshita K, Saito S, Baba Y, Baba H.

Ann Surg Oncol. 2012 Jul;19 Suppl 3:S656-64. doi: 10.1245/s10434-012-2217-6. Epub 2012 Feb 4.


7-Difluoromethoxyl-5,4'-di-n-octyl genistein inhibits the stem-like characteristics of gastric cancer stem-like cells and reverses the phenotype of epithelial-mesenchymal transition in gastric cancer cells.

Cao X, Ren K, Song Z, Li D, Quan M, Zheng Y, Cao J, Zeng W, Zou H.

Oncol Rep. 2016 Aug;36(2):1157-65. doi: 10.3892/or.2016.4848. Epub 2016 Jun 2.


Down-regulation of microRNA-494 via loss of SMAD4 increases FOXM1 and β-catenin signaling in pancreatic ductal adenocarcinoma cells.

Li L, Li Z, Kong X, Xie D, Jia Z, Jiang W, Cui J, Du Y, Wei D, Huang S, Xie K.

Gastroenterology. 2014 Aug;147(2):485-97.e18. doi: 10.1053/j.gastro.2014.04.048. Epub 2014 May 20.


MicroRNA-149 suppresses colorectal cancer cell migration and invasion by directly targeting forkhead box transcription factor FOXM1.

Xu K, Liu X, Mao X, Xue L, Wang R, Chen L, Chu X.

Cell Physiol Biochem. 2015;35(2):499-515. doi: 10.1159/000369715. Epub 2015 Jan 16.


MiR-646 inhibited cell proliferation and EMT-induced metastasis by targeting FOXK1 in gastric cancer.

Zhang P, Tang WM, Zhang H, Li YQ, Peng Y, Wang J, Liu GN, Huang XT, Zhao JJ, Li G, Li AM, Bai Y, Chen Y, Ren YX, Li GX, Wang YD, Liu SD, Wang JD.

Br J Cancer. 2017 Aug 8;117(4):525-534. doi: 10.1038/bjc.2017.181. Epub 2017 Jun 20.


miR-204 regulates the EMT by targeting snai1 to suppress the invasion and migration of gastric cancer.

Liu Z, Long J, Du R, Ge C, Guo K, Xu Y.

Tumour Biol. 2016 Jun;37(6):8327-35. doi: 10.1007/s13277-015-4627-0. Epub 2016 Jan 5.


RUNX3 regulates vimentin expression via miR-30a during epithelial-mesenchymal transition in gastric cancer cells.

Liu Z, Chen L, Zhang X, Xu X, Xing H, Zhang Y, Li W, Yu H, Zeng J, Jia J.

J Cell Mol Med. 2014 Apr;18(4):610-23. doi: 10.1111/jcmm.12209. Epub 2014 Jan 22.


Targeting FoxM1 inhibits proliferation, invasion and migration of nasopharyngeal carcinoma through the epithelial‑to-mesenchymal transition pathway.

Yu C, Chen L, Yie L, Wei L, Wen T, Liu Y, Chen H.

Oncol Rep. 2015 May;33(5):2402-10. doi: 10.3892/or.2015.3834. Epub 2015 Mar 4.


Suppression of forkhead box Q1 by microRNA-506 represses the proliferation and epithelial-mesenchymal transition of cervical cancer cells.

Zhang M, Xu Q, Yan S, Li Z, Yan W, Jia X.

Oncol Rep. 2016 May;35(5):3106-14. doi: 10.3892/or.2016.4651. Epub 2016 Mar 3.


MicroRNA-370 directly targets FOXM1 to inhibit cell growth and metastasis in osteosarcoma cells.

Duan N, Hu X, Yang X, Cheng H, Zhang W.

Int J Clin Exp Pathol. 2015 Sep 1;8(9):10250-60. eCollection 2015.

Supplemental Content

Support Center